Cornell researchers have taken an important step toward harnessing CRISPR gene editing in “targeted, safe and potent” cancer treatment, according to Ailong Ke, professor of chemistry and chemical biology in the College of Arts and Sciences.
Cornell researchers have taken an important step toward harnessing CRISPR gene editing in “targeted, safe and potent” cancer treatment, according to Ailong Ke, professor of chemistry and chemical biology in the College of Arts and Sciences.
Leave A Comment